Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2024
Reporting Period: Second Quarter ended June 30, 2024
This filing serves as a notification that the company issued a press release on August 8, 2024, announcing its financial results for the quarter ended June 30, 2024. The press release is included as Exhibit 99.1.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced press release (Exhibit 99.1) and are not explicitly stated in the body of this Form 8-K.
Material Changes
Comparison to Prior Period: The filing text does not provide specific data regarding material changes in financial performance compared to the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary and Outlook: No specific guidance, outlook, or management commentary is included in the text of this filing. The document solely references the issuance of the press release containing these details.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Important Facts for Investors to Verify
- Review Exhibit 99.1 (Press Release dated August 8, 2024) for actual financial figures, including revenue, net income, and cash flow for the quarter ended June 30, 2024.
- Verify the company's liquidity position and debt levels as reported in the full press release.
- Check for any forward-looking statements or guidance provided in the press release that may not be reflected in this summary filing.
- Note that the information in Item 2.02 and Exhibit 99.1 is furnished but not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.